121 related articles for article (PubMed ID: 14643970)
1. A comparison of human H295R and rat R2C cell lines as in vitro screening tools for effects on aromatase.
Heneweer M; van den Berg M; Sanderson JT
Toxicol Lett; 2004 Jan; 146(2):183-94. PubMed ID: 14643970
[TBL] [Abstract][Full Text] [Related]
2. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells.
Sanderson JT; Boerma J; Lansbergen GW; van den Berg M
Toxicol Appl Pharmacol; 2002 Jul; 182(1):44-54. PubMed ID: 12127262
[TBL] [Abstract][Full Text] [Related]
3. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and induction of aromatase (CYP19) activity by brominated flame retardants in H295R human adrenocortical carcinoma cells.
Cantón RF; Sanderson JT; Letcher RJ; Bergman A; van den Berg M
Toxicol Sci; 2005 Dec; 88(2):447-55. PubMed ID: 16177243
[TBL] [Abstract][Full Text] [Related]
5. Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells.
Caron-Beaudoin É; Denison MS; Sanderson JT
Toxicol Sci; 2016 Jan; 149(1):134-44. PubMed ID: 26464060
[TBL] [Abstract][Full Text] [Related]
6. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?
Sanderson JT; Seinen W; Giesy JP; van den Berg M
Toxicol Sci; 2000 Mar; 54(1):121-7. PubMed ID: 10746939
[TBL] [Abstract][Full Text] [Related]
7. cis-acting elements of the rat aromatase promoter required for cyclic adenosine 3',5'-monophosphate induction in ovarian granulosa cells and constitutive expression in R2C Leydig cells.
Fitzpatrick SL; Richards JS
Mol Endocrinol; 1993 Mar; 7(3):341-54. PubMed ID: 8387157
[TBL] [Abstract][Full Text] [Related]
8. Expression of aromatase cytochrome P450 in rat H540 Leydig tumor cells.
Young M; Lephart ED; McPhaul MJ
J Steroid Biochem Mol Biol; 1997; 63(1-3):37-44. PubMed ID: 9449204
[TBL] [Abstract][Full Text] [Related]
9. Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells.
Sanderson T; Renaud M; Scholten D; Nijmeijer S; van den Berg M; Cowell S; Guns E; Nelson C; Mutarapat T; Ruchirawat S
Eur J Pharmacol; 2008 Sep; 593(1-3):92-8. PubMed ID: 18639541
[TBL] [Abstract][Full Text] [Related]
10. Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
Watanabe M; Noda M; Nakajin S
J Endocrinol; 2006 Jan; 188(1):59-68. PubMed ID: 16394175
[TBL] [Abstract][Full Text] [Related]
11. A steroidogenic factor-1-binding site and cyclic adenosine 3',5'-monophosphate response element-like elements are required for the activity of the rat aromatase promoter in rat Leydig tumor cell lines.
Young M; McPhaul MJ
Endocrinology; 1998 Dec; 139(12):5082-93. PubMed ID: 9832447
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diindolylmethanes differentially induce cytochrome P450 1A1, 1B1, and 19 in H295R human adrenocortical carcinoma cells.
Sanderson JT; Slobbe L; Lansbergen GW; Safe S; van den Berg M
Toxicol Sci; 2001 May; 61(1):40-8. PubMed ID: 11294972
[TBL] [Abstract][Full Text] [Related]
13. Assessment of chemical effects on aromatase activity using the H295R cell line.
Higley EB; Newsted JL; Zhang X; Giesy JP; Hecker M
Environ Sci Pollut Res Int; 2010 Jun; 17(5):1137-48. PubMed ID: 20087668
[TBL] [Abstract][Full Text] [Related]
14. The structure of cDNA clones encoding the aromatase P-450 isolated from a rat Leydig cell tumor line demonstrates differential processing of aromatase mRNA in rat ovary and a neoplastic cell line.
Lephart ED; Peterson KG; Noble JF; George FW; McPhaul MJ
Mol Cell Endocrinol; 1990 Mar; 70(1):31-40. PubMed ID: 2340950
[TBL] [Abstract][Full Text] [Related]
15. The use of rat Leydig tumor (R2C) and human hepatoma (HEPG2) cells to evaluate potential inhibitors of rat and human steroid aromatase.
Doody KM; Murry BA; Mason JI
J Enzyme Inhib; 1990; 4(2):153-8. PubMed ID: 1965908
[TBL] [Abstract][Full Text] [Related]
16. Diverse mechanisms of control of aromatase gene expression.
McPhaul MJ; Herbst MA; Matsumine H; Young M; Lephart ED
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):341-6. PubMed ID: 8476747
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the rat aromatase gene in ovarian granulosa cells and R2C Leydig cells.
Fitzpatrick SL; Richards JS
J Steroid Biochem Mol Biol; 1993 Mar; 44(4-6):429-33. PubMed ID: 8476756
[TBL] [Abstract][Full Text] [Related]
18. Identification of a cyclic adenosine 3',5'-monophosphate-response element in the rat aromatase promoter that is required for transcriptional activation in rat granulosa cells and R2C leydig cells.
Fitzpatrick SL; Richards JS
Mol Endocrinol; 1994 Oct; 8(10):1309-19. PubMed ID: 7854348
[TBL] [Abstract][Full Text] [Related]
19. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R.
Watanabe M; Nakajin S
J Endocrinol; 2004 Jan; 180(1):125-33. PubMed ID: 14709151
[TBL] [Abstract][Full Text] [Related]
20. Co-culture of primary human mammary fibroblasts and MCF-7 cells as an in vitro breast cancer model.
Heneweer M; Muusse M; Dingemans M; de Jong PC; van den Berg M; Sanderson JT
Toxicol Sci; 2005 Feb; 83(2):257-63. PubMed ID: 15525692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
